ImmunoPrecise Antibodies Ltd. (HYFT) — Long-term Investment Intensity
ImmunoPrecise Antibodies Ltd. (HYFT) has a Long-term Investment Intensity of 0.1% as of April 2023. Long-term investments of $115.00K represent 0.1% of total assets of $77.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check ImmunoPrecise Antibodies Ltd. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
ImmunoPrecise Antibodies Ltd. Long-term Investment Intensity (2022–2023)
This chart shows how ImmunoPrecise Antibodies Ltd.'s Long-term Investment Intensity has evolved across 2 annual periods from 2022 to 2023. As of April 2023, the intensity stands at 0.1%, reflecting long-term investments of $115.00K against total assets of $77.81 Million USD. Explore ImmunoPrecise Antibodies Ltd. debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for ImmunoPrecise Antibodies Ltd. (2022–2023)
The table below presents the year-by-year Long-term Investment Intensity for ImmunoPrecise Antibodies Ltd. from 2022 to 2023, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ImmunoPrecise Antibodies Ltd. stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.1% | $115.00K | $77.81 Million | ▼ 0.0 pp |
| 2022 | 0.2% | $142.00K | $93.49 Million | — |